- Also called:
- Lewy body dementia
dementia with Lewy bodies
-
What is dementia with Lewy bodies?
Dementia with Lewy bodies (DLB) is a chronic, progressive disease characterized by declining intellectual capacity, loss of neurons in certain brain regions, and abnormal deposits of alpha-synuclein protein known as Lewy bodies.
Symptoms often include autonomic disturbances, changes in behavior and cognition, movement and sleep disorders, visual hallucinations, and loss of visual and spatial abilities. Cognitive decline can impair the ability to perform daily activities, and patients may experience depression, anxiety, or delusions. Physical activity may be limited due to parkinsonism symptoms.
Age is a major risk factor, especially for those 65 and older, and men are more likely to be affected than women. Other risk factors include depression, Parkinson's disease, or rapid eye movement sleep behavior disorder (RBD). Variations in genes, including APOE, SNCA, and GBA, are also linked to increased risk.
There is no cure, but treatments can lessen symptoms. Diagnosis is challenging and may require evaluation by various specialists.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What are the main symptoms of dementia with Lewy bodies?
Symptoms of dementia with Lewy bodies usually include changes in behavior and cognition, autonomic disturbances, and movement and sleep disorders. Visual hallucinations and loss of visual and spatial abilities are common symptoms. Those affected may experience difficulty concentrating, reduced ability to smell, restless legs syndrome, insomnia, RBD, and sensitivity to temperature changes.
Changes in autonomic nervous system function can cause irregular blood pressure and heart rate, fainting and dizziness, excessive sweating, bladder control loss, digestion issues, and bowel problems. Cognitive decline can affect the ability to perform daily activities. Parkinsonism symptoms, such as muscle stiffness, tremor, slow walking, and balance and coordination issues, may limit physical activity. Some patients also show anxiety, depression, agitation, apathy, delusions, or paranoia. Memory problems often occur in later stages.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How is dementia with Lewy bodies different from other types of dementia?
Dementia with Lewy bodies (DLB) is a chronic, progressive condition characterized by declining intellectual capacity, particularly affecting attention and visual-spatial processing, and is the second most common form of dementia after Alzheimer's disease.
DLB is related to Parkinson disease dementia (PDD), since both are associated with the accumulation of Lewy bodies, which are abnormal deposits of alpha-synuclein in the brain. The abnormal buildup of alpha-synuclein occurs in several different parts of the brain, including the basal ganglia, the brainstem, the diencephalon, and the neocortex. DLB is also associated with reduced activity in the brainās cholinergic system, which plays an essential role in regulating attention and cognition. In addition, DLB is associated with widespread atrophy of cerebral tissue and deposition of amyloid in the brain, similar to what is seen in Alzheimerās disease.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What causes dementia with Lewy bodies to develop in the brain?
Dementia with Lewy bodies (DLB) is related to the accumulation of alpha-synuclein protein deposits, known as Lewy bodies, in the brain, which results in the loss of neurons. This buildup occurs in areas such as the basal ganglia, brainstem, diencephalon, and neocortex.
The loss of dopaminergic neurons in the substantia nigra, a key site for dopamine production, is associated with alpha-synuclein deposition. This affects memory, learning, attention, behavior, cognition, mood, motivation, movement, and sleep. DLB is also linked to reduced activity in the cholinergic system, which regulates attention and cognition, and is associated with cerebral tissue atrophy and amyloid deposition.
Age is a significant risk factor, particularly for those over 65, and men are more likely to be affected than women. Other risk factors include a family history of dementia or Parkinson's disease, depression, Parkinsonās, and variations in genes such as APOE, SNCA, and GBA.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How do doctors diagnose dementia with Lewy bodies?
Diagnosing dementia with Lewy bodies (DLB) can be challenging because its symptoms resemble those of Alzheimer's and even psychological disorders like schizophrenia.
To diagnose DLB, doctors may use imaging tests, neurological exams, blood tests, sleep studies, and a thorough medical history and physical exam. Because DLB has features that overlap with other conditions, patients usually need to be assessed by a team of specialists, such as neurologists, psychiatrists, and geriatricians. Positron emission tomography (PET) can also be useful in diagnosing certain degenerative and metabolic disorders.
5 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What treatments and support options are available for people with dementia with Lewy bodies?
There is no cure for dementia with Lewy bodies, but treatments can help lessen symptoms. Medications such as carbidopa and levodopa can address parkinsonism symptoms, while cholinesterase inhibitors can augment levels of acetylcholine.
Other therapies include physical, speech, and occupational therapy. Mental health counseling, support groups, and palliative care can also help patients cope with symptoms. Memory care facilities are tailored to patients with dementia.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
dementia with Lewy bodies, chronic, progressive disease characterized by the deterioration of intellectual capacity, particularly attention and visual and spatial processing, associated with the widespread loss of neurons in certain regions of the brain. It is the second most common form of dementia, behind Alzheimer disease. Dementia with Lewy bodies is related to Parkinson disease dementia (PDD), in that both are associated with the accumulation of so-called Lewy bodiesāabnormal deposits of a protein known as alpha-synucleināin the brain. Lewy bodies are named for German physician Friedrich Heinrich Lewy, who first described them (1912), in the context of Parkinson disease.
Pathological features
The abnormal buildup of alpha-synuclein occurs in several different parts of the brain, including the basal ganglia, the brainstem, the diencephalon, and the neocortex. Alpha-synuclein deposition is associated in particular with a loss of dopaminergic (dopamine-related) neurons specifically within the substantia nigra, which is located in the brainstem. The substantia nigra is a major site of production of the neurotransmitter dopamine, which plays an important role in memory formation and learning and in helping regulate attention, behavior, cognition, mood, motivation, movement, and sleep.
Dementia with Lewy bodies is also associated with a reduction in activity of the brainās cholinergic system, which serves an essential role in the regulation of attention and cognition. In particular, the neurotransmitter acetylcholine and its receptors, which are central components of the cholinergic system, are depleted extensively in the neocortex. The loss of acetylcholine is suspected of contributing to declines in higher-order cognitive processing observed in patients with dementia with Lewy bodies. Moreover, dementia with Lewy bodies is associated with widespread atrophy of cerebral tissue and deposition of amyloid (an insoluble protein-carbohydrate complex) in the brain, which is similar to cerebral atrophy and the formation of amyloid plaques documented in Alzheimer disease.
" height="20" alt="HEW Logo">
Risk factors
Age is a major risk factor for dementia with Lewy bodies, especially for individuals age 65 and older, and overall, men tend to be affected more often than women. The presence of other conditions, such as depression, Parkinson disease, or rapid eye movement sleep behavior disorder (RBD), indicates one or more additional risk factors. Risk may also be increased by family history. Many individuals who develop dementia with Lewy bodies have a family history of dementia or a family history of Parkinson disease. In addition, variations in certain genes are linked to increased risk, including variants in APOE, SNCA, and GBA.
Symptoms
Symptoms of dementia with Lewy bodies usually center on a combination of autonomic disturbances, changes in behavior and cognition, and the emergence of movement and sleep disorders. Visual hallucinations and loss of visual and spatial abilities (e.g., judging the distances of objects) are common symptoms. Many individuals also experience a reduction in the ability to smell, difficulty concentrating or paying attention, RBD, insomnia, restless legs syndrome, and sensitivity to changes in temperature. Changes in autonomic nervous system function can further result in irregular blood pressure and heart rate, episodes of dizziness and fainting, excessive sweating, digestion issues, loss of bladder control, and constipation and other bowel issues.
Cognitive decline, including reductions in the ability to think, reason, and plan, can affect individualsā ability to carry out day-to-day activities. Many patients also show some degree of depression, apathy, anxiety, or agitation and, in some instances, delusions and paranoia. Physical activity may be limited or impaired by symptoms of parkinsonism, which can include tremor or muscle stiffness, shuffling or slow walking, problems with balance and coordination, and stooped posture. Weak voice and trouble swallowing and writing may also be present. Problems with memory often do not arise until later stages of the disease.
Diagnosis, treatment, and prognosis
Diagnosis of dementia with Lewy bodies is challenging, since the condition resembles Alzheimer disease and may even be confused with psychological disorders such as schizophrenia. Hence, patients typically require evaluation by physicians in different specialties, including neurology, psychiatry, and geriatrics. Diagnostic tools may include a medical history and physical exam, imaging tests, neurological exams, blood tests, and sleep studies.
The trusted destination for professionals, college students, and lifelong learners.
SUBSCRIBE
There is no cure for dementia with Lewy bodies, although there are treatments that may lessen symptoms. Medications that may be used include carbidopa and levodopa (commonly marketed as Sinemet), a dopamine precursor drug combination that addresses symptoms of parkinsonism, and cholinesterase inhibitors, which augment levels of acetylcholine. Other therapeutic approaches include physical therapy, speech therapy, and occupational therapy. Mental health counseling, support groups, and palliative care can help patients learn to cope with their symptoms.
The speed with which symptoms develop and progress depends on various factors, including the age and health of the patient. On average, individuals with dementia with Lewy bodies do not live as long as patients with Alzheimer disease. Nonetheless, life expectancy following diagnosis varies markedly: some patients live as little as two years, and others live as much as two decades.